Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 October 2024 | Story André Damons | Photo Supplied
Deaf awareness Campaign 2024
Boipelo Leteane, Amahle Jemane, Zinzile Sibiya (Speech-Language Pathologist at UAH), Ntsatsi Dingaan-Mokushane, Andani Madzivhandila, Yolanda Nzume (Administration Clerk at UAH) and Dr Phindile Shangase at the Deaf Awareness Campaign at the UFS.

The Department of Speech Therapy and Audiology at Universitas Academic Hospital (UAH), in partnership with the Division of Public Health at the University of the Free State (UFS) recently held their annual Deaf Awareness Campaign with much success.

The campaign, which is the brainchild of Andani Madzivhandila, a Cochlear Implant MAPping Audiologist at Universitas Academic Hospital (UAH), is in its second year and was attended by Deaf students from the UFS, community members and academics from the UFS Faculty of Health Sciences, including Dr Phindile Shangase from the Division of Public Health at the UFS in collaboration with UAH Speech Therapy and Audiology staff.

Purpose of the event

The event took place on 28 September 2024 in the foyer of the Francoise Retief building. September is the International Month for Deaf People. The Department of Otorhinolaryngology and Med-EL assisted with some sponsorship to make the event a success. Ntsatsi Dingaan-Mokushane, the Assistant Director for Speech Therapy and Audiology at UAH, opened the ceremony and highlighted the importance of Deaf Awareness Campaigns in general and further elaborated on the World Federation of the Deaf theme for 2024, which is “Sign up for sign language rights”.

Dr Shangase shared her experiences and challenges of living with hearing loss and how she manages it, and further elaborated that the purpose of the event was to raise awareness of the different types of hearing loss, especially deafness. It was also to raise awareness of the challenges encountered by Deaf people and to discuss available technologies to assist those with hearing loss as well as those who are born profoundly Deaf.

The event is organised to share experiences from professionals, those with hearing loss as well as the Deaf community, to share experiences on coping and managing life with hearing loss as well as deafness. The organisers try to educate the public about Deaf culture, sign language and the experiences of Deaf people and to help combat stereotypes, stigmas and misconceptions surrounding deafness. The event is also to promote inclusion and encourage equal access to education, employment, healthcare as well as breaking down communication barriers and address systemic and social barriers that hinder Deaf individuals’ participation.

Sharing lived experiences

According to Dr Shangase, the event highlighted the progress as well as gaps in support interventions for those who live with hearing loss and deafness. Says Dr Shangase: “Availability of technologies was highlighted as facilitating different forms of participation for those with hearing loss and deafness. However, it was clear that most of the available technologies are not being adopted in workplaces as well as in communities.”

Boipelo Leteane, a parent of a two-year-old child who was born deaf, shared her experiences and her journey before and after her child had undergone a cochlear implant, while Madzivhandila shed some light on the challenges faced by healthcare professionals when hearing loss/deafness is diagnosed and needs to be managed. 

Amahle Jemane also shared her personal experiences and challenges she faces daily as a signing young female in South Africa, where the majority of the population use spoken language, and she uses South African Sign Language (SASL). 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept